Filing Details
- Accession Number:
- 0001131399-10-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-24 12:21:43
- Reporting Period:
- 2010-11-24
- Filing Date:
- 2010-11-24
- Accepted Time:
- 2010-11-24 12:21:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford Middlesex X0 TW8 9GS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2010-11-24 | 1,000,000 | $5.00 | 2,771,374 | No | 4 | P | Indirect | By subsidiary |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By subsidiary |
Footnotes
- Shares are held by GlaxoSmithKline LLC, f/k/a/ SmithKline Beecham Corporation, a wholly owned subsidiary of Reporting Person
Billionaire Hedge Funds
